Literature DB >> 11786399

Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.

Lisa Lai Ping Siu1, John Kwok Cheung Chan, Kit-Fai Wong, Yok-Lam Kwong.   

Abstract

Aberrant methylation of promoter CpG regions is a putative mechanism whereby tumor suppressor genes are inactivated. We used a candidate gene approach to investigate the patterns and significance of this epigenetic change in natural killer (NK) cell malignancies. Thirty-three patients were studied for promoter methylation in five putative tumor suppressor genes by methylation-specific polymerase chain reaction (MSP), which has a sensitivity of 10(-3). The p73 gene was methylated in 94% of cases, a frequency that is the highest known for any human malignancy. In the NK cell lymphoma line NK92, p73 was also completely methylated, and the p73 transcript was correspondingly not detectable by quantitative polymerase chain reaction. Treatment of the cell line with 5-azacytidine, a demethylation reagent, led to demethylation of the p73 promoter and reinduction of p73 gene expression. These results suggested that promoter CpG methylation might be an important mechanism in suppressing p73 gene expression in NK cells. Other methylated genes included hMLH1 (63%), p16 (63%), p15 (48%), and RAR beta (47%). Methylation of two or more genes occurred in 88% of cases. With promoter methylation as a molecular marker, MSP identified two cases of occult marrow metastasis. Interestingly, the primary tumor and metastasis showed different methylation patterns, implying that separate clonal evolutions might have occurred at these sites. Furthermore, MSP also identified tumor infiltration in random oropharyngeal biopsies in a case where histological examination could not show evidence of tumor involvement. We conclude that NK cell malignancies show a specific pattern of promoter methylation, with p73 being consistently involved. These results suggest that p73 may be an important target in the neoplastic transformation of NK cells, and the demonstration of its methylation may serve as a potential molecular tool for NK cell lymphoma detection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786399      PMCID: PMC1867120          DOI: 10.1016/s0002-9440(10)64349-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?

Authors:  E R Fearon
Journal:  J Natl Cancer Inst       Date:  2000-04-05       Impact factor: 13.506

2.  p53 and p73: seeing double?

Authors:  M S Soengas; S W Lowe
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

3.  Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise.

Authors:  S B Baylin; S A Belinsky; J G Herman
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

4.  CpG island methylation in premalignant stages of gastric carcinoma.

Authors:  G H Kang; Y H Shim; H Y Jung; W H Kim; J Y Ro; M G Rhyu
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

5.  Consistent patterns of allelic loss in natural killer cell lymphoma.

Authors:  L L Siu; V Chan; J K Chan; K F Wong; R Liang; Y L Kwong
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.

Authors:  L L Siu; K F Wong; J K Chan; Y L Kwong
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; M Hermann; H M Müller; A Amberger; M Zeschnigk; A Widschwendter; B Abendstein; A G Zeimet; G Daxenbichler; C Marth
Journal:  J Natl Cancer Inst       Date:  2000-05-17       Impact factor: 13.506

Review 8.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

Authors:  S B Baylin; J G Herman
Journal:  Trends Genet       Date:  2000-04       Impact factor: 11.639

9.  Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

Authors:  A K Virmani; A Rathi; S Zöchbauer-Müller; N Sacchi; Y Fukuyama; D Bryant; A Maitra; S Heda; K M Fong; F Thunnissen; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  2000-08-16       Impact factor: 13.506

10.  Hypermethylation of multiple genes in pancreatic adenocarcinoma.

Authors:  T Ueki; M Toyota; T Sohn; C J Yeo; J P Issa; R H Hruban; M Goggins
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

View more
  18 in total

1.  Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population.

Authors:  Abhimanyu Kumar Jha; Mohsen Nikbakht; Veena Jain; Alka Sehgal; Neena Capalash; Jagdeep Kaur
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Authors:  Lorraine Springuel; Elisabeth Losdyck; Pascale Saussoy; Béatrice Turcq; François-Xavier Mahon; Laurent Knoops; Jean-Christophe Renauld
Journal:  Cell Mol Life Sci       Date:  2016-07-19       Impact factor: 9.261

Review 3.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

4.  The association between non-Hodgkin lymphoma and methylation of p73.

Authors:  Jing-Hong Pei; Sai-Qun Luo; Yan Zhong; Jiang-Hua Chen; Hua-Wu Xiao; Wei-Xin Hu
Journal:  Tumour Biol       Date:  2011-08-03

5.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

Review 6.  Update on the World Health Organization classification of peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

7.  HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

Authors:  Can Küçük; Xiaozhou Hu; Javeed Iqbal; Philippe Gaulard; David Klinkebiel; Adam Cornish; Bhavana J Dave; Wing C Chan
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

8.  p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.

Authors:  Wensheng Yan; Jin Zhang; Yanhong Zhang; Yong-Sam Jung; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

Review 9.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

Review 10.  Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.

Authors:  Holbrook Kohrt; Ranjana Advani
Journal:  Leuk Lymphoma       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.